Standard BioTools Inc. (NASDAQ:LAB) Q4 2024 Earnings Call Transcript February 26, 2025
Standard BioTools Inc. misses on earnings expectations. Reported EPS is $-0.09097 EPS, expectations were $-0.07.
Operator: Good day, everyone, and welcome to Standard BioTools’ Fourth Quarter and Full Year 2024 Financial Results Conference Call. As a reminder, this conference is being recorded. It’s now my pleasure to introduce your host, [John Graziano] (ph) from Investor Relations. Please go...
